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Abstract
Most patients undergo traditional open surgery (OSR) for medical 
management of abdominal aortic aneurysms (AAA), but this is often 
associated with prolonged in-hospital recovery and is contraindicated in an 
aging population with higher prevalence of comorbidities. Some clinicians 
have turned towards the less invasive endovascular aneurysm repair 
(EVAR) procedure as another option for AAA management. However, there 
seems to be some conflicting research about EVAR’s long term efficacy. 
Therefore, this review will analyze the efficacy and rate of complications of 
EVAR compared to traditional OSR in patients 60 y.o. and older with AAA.
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An abdominal aortic aneurysm (AAA) is a local dilation of the abdominal 
aorta that occurs when the pressure from inside the artery causes the 
weakened area to bulge out beyond the normal width of the blood vessel. 
Initial presentation of AAA is usually asymptomatic. If left untreated, the 
diameter of the aneurysm can become wider, which can result in an 
increased risk of rupture and death. AAA is traditionally treated by OSR, but 
this procedure is highly invasive and can lead to prolonged in-hospital 
recovery, increased rate of reinterventions, and other major adverse events 
such as MI, respiratory failure, and stroke. EVAR is a minimally invasive 
procedure with promising results such as short-term hospital stays, lower 
perioperative complications, and decreased morbidity. However, very few 
studies have focused on the long-term effects of endografts in AAA. 
Introduction
Methods
• A literature search was completed though PubMed, ClinicalKey, and Google 
Scholar. 
• Keywords: 
• FEVAR; AAA; Open surgery; treatment; Medicare; Repair; 
Endovascular vs. Open Repair; Ruptured AAA; randomized 
controlled trial; hospital stay, long-term outcome; early 
outcome
• Results yielded: 351 articles
• Exclusion criteria:
• Articles published 10+ years ago, patients under 60 y.o., 
systematic review, cost-effectiveness of procedures, studies that 
did not measure length of hospital stay, articles not exclusively 
comparing outcomes from OSR vs. EVAR/FEVAR, studies that did 
not include reinterventions or readmissions after the initial 
procedures.  
• Six articles were selected after application of exclusion criteria.
The results from the six studies in this analysis provided mixed reviews 
on the efficacy and safety of EVAR compared to OSR. Most of the studies 
compared the post-op results from FEVAR/EVAR vs. OSR from 30 days to a 
couple of years. Most found that length of hospital stay for the initial 
procedure was significantly lower in patients who underwent EVAR 
compared to OSR. Studies also revealed that EVAR is related to a decrease 
in major adverse events than OSR. This means that many of the EVAR 
participants experienced greater short-term survival benefits. 
However, most of the studies did not find a significant reduction of 
survival rates past one year for endovascular repair, nor did they find a 
decrease in reintervention rates between the two treatments. There was 
also mixed consensus about rate of perioperative mortality within 30 days, 
which could be influenced by surgeon’s technique, limitations of the 
surgical centers, and patient’s comorbidities and access to healthcare. 
This shows that EVAR might have better short and mid-term benefits, 
but long-term outcomes are similar if not worse than OSR. 
The results that were collected and analyzed from the six studies have 
shown optimistic data on the short-term and mid-term benefits of EVAR for 
treatment of AAA. However, due to several limitations, such as inability to 
exclude bias, small sample size, short-term follow up periods, and lack of 
randomization, the data most likely cannot provide a great defense for 
positive long-term outcomes in (F)EVAR. 
Discussion Results 
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In Adult Patients 60+ y.o. With AAA, Would (F)EVAR Lead To Least Amount 
Of Post-operative Complications Than Traditional OSR?
Current research provides mostly positive reviews on the efficacy and 
safety of EVAR as an alternative treatment for AAA. Compared with OSR, 
EVAR has proven itself to offer advantages of shorter hospital stays, fewer 
major complications, and similar survival benefit to OSR. However, in mid-
term and long-term reviews, late complications from EVAR, which includes 
increased rates of graft-related complications and higher rates of 
reintervention, were found more likely to occur in patients between the 
ages of 60-79 years old. More research needs to be conducted to provide 
sufficient evidence that affirms EVAR as an effective and reliable alternative 
to OSR in the elective treatment of AAA.
Conclusion
Key: S = significant; NS = not significant; N/A = Not Available; O = Octogenarians; Y = Patients younger than 80 y.o.
* = Comparison between Octogenarians only 
The six articles that were selected include two randomized 
controlled trials (RCT) and four cohort studies. These studies 
used common outcome measurements to compare the results 
between the two procedures including survival rates > 1-year 
post-op, length of hospital stay, major adverse events, 
mortality rates within 30 days post-op, and rates of 
reintervention. 
Becquemin et al (2011) found that EVAR was associated 
with advantages such as shorter hospital stays, fewer major 
complications, and similar survival benefit to OSR. Raval et al 
((2010) revealed elderly patients who underwent OSR had a 
greater risk of developing infectious, pulmonary, cardiac, and 
renal complications compared to the EVAR group. 
Schermerhorn et al (2008) found that all major medical 
complications, including MI and pneumonia, were less likely 
after EVAR repair than after OSR. However, in the same study, 
they also found reinterventions related to AAA were more 
common in EVAR than in OSR. 
The six studies provided different, but mostly positive 



















N/S N/S N/S N/S S
De Bruin et al 
(2010)
S N/S N/S N/S N/A
Deery et al 
(2017)
N/S N/S S N/S S
Raval et al 
(2010)
(O vs. Y) *




S N/S S N/S S
Timaran et al 
(2016)
(O vs. Y)
N/S N/S S S N/S
Table 1. Comparison of Results: EVAR/FEVAR vs. OSR
